Literature DB >> 10617143

Phe(13),Tyr(19)-melanin-concentration hormone and the blood-brain barrier: role of protein binding.

A J Kastin1, V Akerstrom, L Hackler, J E Zadina.   

Abstract

Melanin-concentrating hormone (MCH), found both peripherally and centrally, is involved in food ingestion. Although its expression in brain is increased by fasting, it is not known whether it crosses the blood-brain barrier (BBB). Use of the sensitive method of multiple-time regression analysis has shown that almost all of the peptides and polypeptides tested cross the BBB at a rate faster than the vascular marker albumin. With this same method, however, we found that the 19-amino acid 125I-Phe13,Tyr19-MCH did not cross faster than 99mTc-albumin. Several mechanisms were excluded as possible explanations for the slow rate of influx. These included degradation, association with capillary endothelial cells, and transport from brain to blood. When Phe13,Tyr19-MCH was perfused in blood-free buffer, however, it entered the brain significantly faster than albumin. This suggested protein binding as an explanation for the slow rate of influx when the MCH was administered in blood. Protein binding was confirmed by capillary zone electrophoresis, which showed that almost all of the Phe13,Tyr19-MCH added to blood migrated with a large-molecular-weight substance. Sodium dodecyl sulfate-capillary gel electrophoresis of Phe13,Tyr19-MCH in buffer additionally showed that the MCH aggregated as a trimer, a factor not preventing its influx by blood-free perfusion. Thus, the results show that blood-borne Phe13,Tyr19-MCH does not significantly cross the BBB, probably because of its binding to serum proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10617143     DOI: 10.1046/j.1471-4159.2000.0740385.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 2.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

3.  The fasting polypeptide FGF21 can enter brain from blood.

Authors:  Hung Hsuchou; Weihong Pan; Abba J Kastin
Journal:  Peptides       Date:  2007-10-18       Impact factor: 3.750

Review 4.  Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

5.  Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.

Authors:  Abba J Kastin; Victoria Akerstrom; Weihong Pan
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

6.  Circulating TGF-beta1 does not cross the intact blood-brain barrier.

Authors:  Abba J Kastin; Victoria Akerstrom; Weihong Pan
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

7.  Restored TDCA and valine levels imitate the effects of bariatric surgery.

Authors:  Markus Quante; Jasper Iske; Timm Heinbokel; Bhavna N Desai; Hector Rodriguez Cetina Biefer; Yeqi Nian; Felix Krenzien; Tomohisa Matsunaga; Hirofumi Uehara; Ryoichi Maenosono; Haruhito Azuma; Johann Pratschke; Christine S Falk; Tammy Lo; Eric Sheu; Ali Tavakkoli; Reza Abdi; David Perkins; Maria-Luisa Alegre; Alexander S Banks; Hao Zhou; Abdallah Elkhal; Stefan G Tullius
Journal:  Elife       Date:  2021-06-22       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.